Related Experiment Video
Updated: Jul 16, 2026

04:38
A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Reduced medication access: a marker for vulnerability in US stroke survivors
Deborah A Levine1, Catarina I Kiefe, George Howard
1Deep South Center on Effectiveness Research, Birmingham VA Medical Center, AL, USA. dlevine@uab.edu
Stroke
|March 31, 2007
Summary
Medication access for stroke survivors worsened between 1997 and 2004, with more individuals unable to afford prescriptions. This trend highlights growing barriers to secondary stroke prevention care.
Area of Science:
- Public Health
- Cardiovascular Research
- Health Services Research
Background:
- Medication access is vital for secondary stroke prevention.
- Disparities in access and care barriers exist among US stroke survivors.
Purpose of the Study:
- To assess medication access and care barriers in a national sample of US stroke survivors.
- To examine changes in medication access across US regions and over time.
Main Methods:
- Analysis of the National Health Interview Survey (1997-2004) data.
- Inclusion of 5840 black or white stroke survivors aged 45 years and older.
- Logistic regression used to adjust for demographic, clinical, and socioeconomic factors.
Main Results:
- In 2004, an estimated 76,000 stroke survivors could not afford medications.
- Lower medication affordability was linked to younger age (<65), Black race, female sex, high comorbidity, and low health status.
- Barriers included lack of transportation, no health insurance, no usual place of care, low income, and high out-of-pocket expenses.
- Medication unaffordability increased from 8.1% in 1997 to 12.7% in 2004, with increases across most US regions.
Conclusions:
- A significant and growing population of stroke survivors faces reduced medication access and increased healthcare barriers.
- This trend may lead to a rise in recurrent stroke incidence.
- Targeted interventions are needed to address these access and care disparities.
Related Concept Videos
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...